Please enable JavaScript.
Coggle requires JavaScript to display documents.
Anti-fungal drug (Subcutaneous and systemic (Amphotericin B :fire:…
Anti-fungal drug
-
Superficial
-
Nyastatin :fire:
-
Treatment for:
- Oropharyngeal candidiasis (orally)
- Vulvovaginal candidiasis (intravaginal)
- Cutaneous candidiasis (topical)
-
-
Terbinafine :fire:
-
-
-
Accumulate in breast milk, should not be given to nursing mother :warning:
- Fungi wall made with CHITIN rather than peptidoglycan
- Cell membrane contains ERGOSTEROL rather than cholesterol
-
-
Beta 1,4 gluten synthase produce membrane
1,4 alpha demethylase essential for ergosterol formation
-
Azoles: Inhibit Alpha 14 demethylase --> no formation of ergosterol, disrupts membrane structure and formation
Echinocandins: Inhibits beta 1-3 gluten synthase --> stops production fo gluants (main component of cell wall)
-
-
Fluorinated pyrimidine analogue, enters via cytosine specific permeases converted by cytosine deaminase to 5-FU, enzyme is absent in mammal and only present in fungi
5-FU becomes FUTP incorporated into fungal RNA in place of uridylic acid, inhibit proteins synthesis
5-FU metabolised to FdUMP which is a potent inhibitor of thymidylate synthase, key enzyme for DNA synthesis
-
-
-
-
-
-
Inhibit squalene epioxidase, block biosynthesis of ergosterol